Pfizer And BioNTech Seek Covid Vaccine Approval For 12-15-Year Olds In EU
Frankfurt, Germany: Pfizer/BioNTech said Friday they have requested that European controllers approve their Covid-19 antibody for 12 to 15-year-old, following a comparable move in the United States recently.
The organizations have presented a solicitation with the European Medicines Agency (EMA) to extend the current crisis endorsement for their hit to incorporate "youths 12 to 15 years old", they said in an articulation.
BioNTech CEO Ugur Sahin said Thursday the hit could be accessible for those age bunches from June.

Comments
Post a Comment